Academic Radiology
Volume 16, Issue 10 , Pages 1263-1271 , October 2009

Chemical Shift MRI: Is There any Contribution to Morphologic Evaluation of Solid Breast Masses?

  • Gokhan Gokalp, MD

      Affiliations

    • Department of Radiology, Uludag University Medical Faculty, Gorukle, Bursa, Turkey
    • Corresponding Author InformationAddress correspondence to: G.G.
    • ,
  • Ugur Topal, MD

      Affiliations

    • Department of Radiology, Uludag University Medical Faculty, Gorukle, Bursa, Turkey
    • ,
  • Naile Bolca, MD

      Affiliations

    • Department of Radiology, Uludag University Medical Faculty, Gorukle, Bursa, Turkey
    • ,
  • Ilker Ercan, PhD

      Affiliations

    • Department of Biostatistics, Uludag University Medical Faculty, Gorukle, Bursa, Turkey

Received 19 June 2008 ,Accepted 22 May 2009.

References 

  1. Erguvan-Dogan B, Whitman GJ, Kushwaha AC, et al. BI-RADS-MRI: a primer. AJR Am J Roentgenol. 2006;187:152–160
  2. Tozaki M, Fukuda K. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. AJR Am J Roentgenol. 2006;187:330–337
  3. Ghai S, Muradali D, Bukhanov K, et al. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol. 2005;185:481–487
  4. Rausch DR, Hendrick RE. How to optimize clinical breast MR imaging practices and techniques on your 1.5-T system. Radiographics. 2006;26:1469–1484
  5. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology. 1994;191:625–631
  6. Boetes C, Strijk SP, Holland R, et al. False-negative MR imaging of malignant breast tumors. Eur Radiol. 1997;7:1231–1234
  7. Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology. 2002;224:881–888
  8. Hood MN, Ho VB, Smirniotopoulos JG, et al. Chemical shift: the artifact and clinical tool revisited. Radiographics. 1999;19:357–371
  9. Gabriel H, Pizzitola V, McComb EN, et al. Adrenal lesions with heterogeneous suppression on chemical shift imaging: clinical implications. J Magn Reson Imaging. 2004;19:308–316
  10. Gabriel H, Pizzitola V, McComb EN, et al. Fat in liver metastasis from renal cell carcinoma detected by chemical shift MR imaging. J Magn Reson Imaging. 2004;19:308–316
  11. Yu JS, Rofsky NM. Dynamic subtraction MR imaging of the liver: advantages and pitfalls. AJR Am J Roentgenol. 2003;180:1351–1357
  12. Savci G, Yazici Z, Sahin N, et al. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol. 2006;186:130–135
  13. Israel GM, Hindman N, Hecht E, et al. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol. 2005;184:1868–1872
  14. American College of Radiology. Breast imaging reporting and data system atlas (BI-RADS atlas). Reston, VA: American College of Radiology; 2003;
  15. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model. RadioGraphics. 1999;19:79–92
  16. Stavros AT. Ultrasound of solid breast nodules: distinguishing benign from malignant. In:  Stavros AT editors. Breast ultrasound. Philadelphia, PA: Lippincott Williams & Wilkins; 2004;p. 445–527
  17. Hong AS, Rosen EL, Soo MS, Baker JA. BI-RADS for sonography: positive and negative predictive values of sonographic features. AJR Am J Roentgenol. 2005;184:1260–1265
  18. Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995;196:123–134
  19. Reichenbach JR, Hopfe J, Rauscher A, et al. Subtraction of in-phase and opposed-phase images in dynamic MR mammography. J Magn Reson Imaging. 2005;21:565–575

PII: S1076-6332(09)00313-4

doi: 10.1016/j.acra.2009.05.014

Academic Radiology
Volume 16, Issue 10 , Pages 1263-1271 , October 2009

Article Tools

* Image Usage & Resolution